Publicaties
Gekozen filters:
Gekozen filters:
ANtiangiogenic Second-line Lung cancer Meta-Analysis on individual patient data in non-small cell lung cancer: ANSELMA KU Leuven
BACKGROUND: Now that immunotherapy plus chemotherapy (CT) is one standard option in first-line treatment of advanced non-small cell lung cancer (NSCLC), there exists a medical need to assess the efficacy of second-line treatments (2LT) with antiangiogenics (AA). We performed an individual patient data meta-analysis to validate the efficacy of these combinations as 2LT. METHODS: Randomised trials of AA plus standard 2LT compared to 2LT alone that ...
2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up KU Leuven Universiteit Antwerpen
To complement the existing treatment guidelines for all tumour types, ESMO organises consensus conferences to focus on specific issues in each type of tumour. The 2nd ESMO Consensus Conference on Lung Cancer was held on 11-12 May 2013 in Lugano. A total of 35 experts met to address several questions on non-small-cell lung cancer (NSCLC) in each of four areas: pathology and molecular biomarkers, first-line/second and further lines in advanced ...
The International Association for the Study of Lung Cancer lung cancer staging project : overview of challenges and opportunities in revising the nodal classification of lung cancer Universiteit Gent Universiteit Antwerpen
Treatment for non small cell lung cancer, small cell lung cancer and pleural mesothelioma within the EORTC Lung Cancer Group: past, present and future Universiteit Gent
The International Association for the Study of Lung Cancer Lung Cancer Staging Project Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer KU Leuven
INTRODUCTION: Nodal status is considered to be one of the most reliable indicators of the prognosis in patients with lung cancer and thus is indispensable in determining the optimal therapeutic options. We sought to determine whether the current nodal (N) descriptors should be maintained or revised for the next edition (8th) of the International Lung Cancer Staging System. METHODS: The new International Association for the Study of Lung Cancer ...
IDENTIFICATION AND CHARACTERIZATION OF LONG TERM SURVIVAL POPULATION IN NON-SMALL-CELL LUNG CANCER PATIENTS TREATED WITH IMMUNOTHERAPIES Universiteit Hasselt
OBJECTIVES: The aim of the study was to identify and characterize long term survival population of advanced non–small-cell lung cancer patients treated with immunotherapy. METHODS: Data from 717 patients coming from two expanded used program and from two randomized trials evaluating the efficacy of CIMAvaxEGF and Vaxira in patients with advanced NSCLC, were used. Mixture models were fitted to Overall Survival with one or two population ...